| n (%) . | . | |
|---|---|---|
| Postoperative complication | 340/727 (46.8) | |
| Missing data | 66 | |
| Anastomotic leak | 35/727 (4.8) | |
| Gastric conduit necrosis | 0/727 (0.0) | |
| Ileus | 12/727 (1.7) | |
| Small bowel obstruction | 4/727 (0.6) | |
| Feeding J-tube complication | 7/727 (1.0) | |
| Postoperative bleeding | 1/727 (0.1) | |
| Chylothorax | 41/727 (5.6) | |
| Recurrent laryngeal nerve paralysis | 1/727 (0.1) | |
| Respiratory failure | 36/727 (4.9) | |
| Pneumonia | 185/727 (25.5) | |
| Pleural effusion | 58/727 (8.0) | |
| Chest drain for air leak >10 days | 0/727 (0.0) | |
| Septicemia | 14/727 (1.9) | |
| Pulmonary embolism | 10/727 (1.4) | |
| Deep vein thrombosis | 8/727 (1.1) | |
| Renal failure | 0/727 (0.0) | |
| Atrial fibrillation | 91/727 (12.5) | |
| Stroke | 1/727 (0.1) | |
| Clavien–Dindo score | ||
| I | 18/703 (2.6) | |
| II | 185/703 (26.3) | |
| IIIa | 47/703 (6.7) | |
| IIIb | 18/703 (2.5) | |
| IVa | 43/703 (6.1) | |
| IVb | 4/703 (0.1) | |
| V | 10/703 (1.4) | |
| Missing | 26 | |
| Clavien–Dindo score ≥ IIIa | 122/702 (17.4) | |
| Clavien–Dindo score ≥ IIIb | 75/702 (10.7) | |
| Surgical re-intervention for any cause | 50/793 (6.3) | |
| ICU re-admission | 41/623 (6.6) | |
| Median length of hospital stay in days (IQR) | 10 (7–14) | |
| Missing data hospital stay | 29 | |
| 30-day mortality | 15/785 (1.9) | |
| 90-day mortality | 39/785 (5.0) | |
| 1-year survival | 564/697 (80.9) | |
| 3-year survival | 258/556 (46.4) | |
| 5-year survival | 132/487 (27.1) | |
| n (%) . | . | |
|---|---|---|
| Postoperative complication | 340/727 (46.8) | |
| Missing data | 66 | |
| Anastomotic leak | 35/727 (4.8) | |
| Gastric conduit necrosis | 0/727 (0.0) | |
| Ileus | 12/727 (1.7) | |
| Small bowel obstruction | 4/727 (0.6) | |
| Feeding J-tube complication | 7/727 (1.0) | |
| Postoperative bleeding | 1/727 (0.1) | |
| Chylothorax | 41/727 (5.6) | |
| Recurrent laryngeal nerve paralysis | 1/727 (0.1) | |
| Respiratory failure | 36/727 (4.9) | |
| Pneumonia | 185/727 (25.5) | |
| Pleural effusion | 58/727 (8.0) | |
| Chest drain for air leak >10 days | 0/727 (0.0) | |
| Septicemia | 14/727 (1.9) | |
| Pulmonary embolism | 10/727 (1.4) | |
| Deep vein thrombosis | 8/727 (1.1) | |
| Renal failure | 0/727 (0.0) | |
| Atrial fibrillation | 91/727 (12.5) | |
| Stroke | 1/727 (0.1) | |
| Clavien–Dindo score | ||
| I | 18/703 (2.6) | |
| II | 185/703 (26.3) | |
| IIIa | 47/703 (6.7) | |
| IIIb | 18/703 (2.5) | |
| IVa | 43/703 (6.1) | |
| IVb | 4/703 (0.1) | |
| V | 10/703 (1.4) | |
| Missing | 26 | |
| Clavien–Dindo score ≥ IIIa | 122/702 (17.4) | |
| Clavien–Dindo score ≥ IIIb | 75/702 (10.7) | |
| Surgical re-intervention for any cause | 50/793 (6.3) | |
| ICU re-admission | 41/623 (6.6) | |
| Median length of hospital stay in days (IQR) | 10 (7–14) | |
| Missing data hospital stay | 29 | |
| 30-day mortality | 15/785 (1.9) | |
| 90-day mortality | 39/785 (5.0) | |
| 1-year survival | 564/697 (80.9) | |
| 3-year survival | 258/556 (46.4) | |
| 5-year survival | 132/487 (27.1) | |
| n (%) . | . | |
|---|---|---|
| Postoperative complication | 340/727 (46.8) | |
| Missing data | 66 | |
| Anastomotic leak | 35/727 (4.8) | |
| Gastric conduit necrosis | 0/727 (0.0) | |
| Ileus | 12/727 (1.7) | |
| Small bowel obstruction | 4/727 (0.6) | |
| Feeding J-tube complication | 7/727 (1.0) | |
| Postoperative bleeding | 1/727 (0.1) | |
| Chylothorax | 41/727 (5.6) | |
| Recurrent laryngeal nerve paralysis | 1/727 (0.1) | |
| Respiratory failure | 36/727 (4.9) | |
| Pneumonia | 185/727 (25.5) | |
| Pleural effusion | 58/727 (8.0) | |
| Chest drain for air leak >10 days | 0/727 (0.0) | |
| Septicemia | 14/727 (1.9) | |
| Pulmonary embolism | 10/727 (1.4) | |
| Deep vein thrombosis | 8/727 (1.1) | |
| Renal failure | 0/727 (0.0) | |
| Atrial fibrillation | 91/727 (12.5) | |
| Stroke | 1/727 (0.1) | |
| Clavien–Dindo score | ||
| I | 18/703 (2.6) | |
| II | 185/703 (26.3) | |
| IIIa | 47/703 (6.7) | |
| IIIb | 18/703 (2.5) | |
| IVa | 43/703 (6.1) | |
| IVb | 4/703 (0.1) | |
| V | 10/703 (1.4) | |
| Missing | 26 | |
| Clavien–Dindo score ≥ IIIa | 122/702 (17.4) | |
| Clavien–Dindo score ≥ IIIb | 75/702 (10.7) | |
| Surgical re-intervention for any cause | 50/793 (6.3) | |
| ICU re-admission | 41/623 (6.6) | |
| Median length of hospital stay in days (IQR) | 10 (7–14) | |
| Missing data hospital stay | 29 | |
| 30-day mortality | 15/785 (1.9) | |
| 90-day mortality | 39/785 (5.0) | |
| 1-year survival | 564/697 (80.9) | |
| 3-year survival | 258/556 (46.4) | |
| 5-year survival | 132/487 (27.1) | |
| n (%) . | . | |
|---|---|---|
| Postoperative complication | 340/727 (46.8) | |
| Missing data | 66 | |
| Anastomotic leak | 35/727 (4.8) | |
| Gastric conduit necrosis | 0/727 (0.0) | |
| Ileus | 12/727 (1.7) | |
| Small bowel obstruction | 4/727 (0.6) | |
| Feeding J-tube complication | 7/727 (1.0) | |
| Postoperative bleeding | 1/727 (0.1) | |
| Chylothorax | 41/727 (5.6) | |
| Recurrent laryngeal nerve paralysis | 1/727 (0.1) | |
| Respiratory failure | 36/727 (4.9) | |
| Pneumonia | 185/727 (25.5) | |
| Pleural effusion | 58/727 (8.0) | |
| Chest drain for air leak >10 days | 0/727 (0.0) | |
| Septicemia | 14/727 (1.9) | |
| Pulmonary embolism | 10/727 (1.4) | |
| Deep vein thrombosis | 8/727 (1.1) | |
| Renal failure | 0/727 (0.0) | |
| Atrial fibrillation | 91/727 (12.5) | |
| Stroke | 1/727 (0.1) | |
| Clavien–Dindo score | ||
| I | 18/703 (2.6) | |
| II | 185/703 (26.3) | |
| IIIa | 47/703 (6.7) | |
| IIIb | 18/703 (2.5) | |
| IVa | 43/703 (6.1) | |
| IVb | 4/703 (0.1) | |
| V | 10/703 (1.4) | |
| Missing | 26 | |
| Clavien–Dindo score ≥ IIIa | 122/702 (17.4) | |
| Clavien–Dindo score ≥ IIIb | 75/702 (10.7) | |
| Surgical re-intervention for any cause | 50/793 (6.3) | |
| ICU re-admission | 41/623 (6.6) | |
| Median length of hospital stay in days (IQR) | 10 (7–14) | |
| Missing data hospital stay | 29 | |
| 30-day mortality | 15/785 (1.9) | |
| 90-day mortality | 39/785 (5.0) | |
| 1-year survival | 564/697 (80.9) | |
| 3-year survival | 258/556 (46.4) | |
| 5-year survival | 132/487 (27.1) | |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
